✦ LIBER ✦

PCN116 ANALYSIS OF THE EQ-5D QUESTIONNAIRE FOR PATIENTS WITH ADVANCED HER2-POSITIVE GASTRIC CANCER (HER2+ AGC) BASED ON THE TRASTUZUMAB FOR GASTRIC CANCER (TOGA) STUDY

✍ Scribed by R Aultman; A Urspruch

Book ID: 118614206
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 79 KB
Volume: 13
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(11)72011-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of trastuzumab in Japanese pati

Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study

✍ Sawaki, Akira; Ohashi, Yasuo; Omuro, Yasushi; Satoh, Taroh; Hamamoto, Yasuo; Bok 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 268 KB

PCN20 Analysis of Using Trastuzumab for

PCN20 Analysis of Using Trastuzumab for the Treatment of Advanced Gastric Cancer With HER2 Positive

✍ Lechuga, D.; Gay, J.G.; Alva, M.; Sanchez-kobayashi, R. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Cost-effectiveness analysis of trastuzum

Cost-effectiveness analysis of trastuzumab to treat HER2-positive advanced gastric cancer based on the randomised ToGA trial

✍ Shiroiwa, T; Fukuda, T; Shimozuma, K 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 490 KB

Self-Rated Pain Assessment by Patients W

Self-Rated Pain Assessment by Patients With HER2-Positive Advanced Gastric/GEJ Cancer Treated With 5-FU/Capecitabine and Cisplatin With or Without Trastuzumab: Exploratory QOL Analysis From the Phase III ToGA Study

✍ Yoon-Koo Kang; Lin Shen; Mikhail Lichinitser; Brad L. Stanford; Manuel Philco; Y 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 53 KB

3032 POSTER Health-related Quality of Li

3032 POSTER Health-related Quality of Life in Patients With HER2-positive Advanced Gastric or Gastroesophageal Junction Cancer With High HER2 Expression Levels – Exploratory Analysis of the Phase III ToGA Study

✍ L. Shen; Y.K. Kang; M. Lichinitser; H.C. Chung; A. Ohtsu; Y.J. Bang; E. Van Cuts 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Phase Ib Study of Buparlisib plus Trastu

Phase Ib Study of Buparlisib plus Trastuzumab in Patients with HER2-Positive Advanced or Metastatic Breast Cancer That Has Progressed on Trastuzumab-Based Therapy

✍ Saura, C.; Bendell, J.; Jerusalem, G.; Su, S.; Ru, Q.; De Buck, S.; Mills, D.; R 📂 Article 📅 2014 🏛 American Association for Cancer Research 🌐 English ⚖ 898 KB